Published in Cancer Weekly, October 18th, 2011
"The 5-year cumulative effective dose was 5 mSv. Subjects with at least one 'potentially significant extrapulmonary incidental finding' (PS-IF) were extracted from the study database. An...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.